Total Payments
$5,991
2024 Payments
$3,097
Companies
29
Transactions
244
Medicare Patients
5,477
Medicare Billing
$398,814
Payment Breakdown by Category
Food & Beverage$4,997 (83.4%)
Travel$980.70 (16.4%)
Education$13.89 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,997 | 240 | 83.4% |
| Travel and Lodging | $980.70 | 3 | 16.4% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,445 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $853.37 | 82 | $0 (2024) |
| Merck Sharp & Dohme LLC | $491.93 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $364.31 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $311.06 | 17 | $0 (2024) |
| Abbott Laboratories | $297.36 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $294.65 | 20 | $0 (2023) |
| iRhythm Technologies, Inc. | $196.98 | 11 | $0 (2024) |
| Novo Nordisk Inc | $183.44 | 3 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $174.49 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,097 | 89 | Boston Scientific Corporation ($1,418) |
| 2023 | $1,522 | 66 | Merck Sharp & Dohme LLC ($199.27) |
| 2022 | $866.67 | 51 | Novartis Pharmaceuticals Corporation ($227.23) |
| 2021 | $506.66 | 38 | Novartis Pharmaceuticals Corporation ($216.93) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.74 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $135.71 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: DIABETES | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 10/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $65.99 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $1.53 | General |
| Category: Cardiovascular | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,681 | 2,819 | $500,257 | $127,617 |
| 2022 | 6 | 1,700 | 2,971 | $500,391 | $128,812 |
| 2021 | 8 | 1,197 | 2,491 | $349,019 | $98,395 |
| 2020 | 11 | 899 | 1,471 | $191,131 | $43,990 |
Total Patients
5,477
Total Services
9,752
Medicare Billing
$398,814
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 768 | 1,388 | $398,356 | $103,898 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 263 | $51,285 | $13,702 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 656 | 1,013 | $45,585 | $8,750 | 19.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,624 | $494.50 | 30.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 15 | 68 | $2,312 | $465.43 | 20.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 16 | 73 | $1,095 | $306.60 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 760 | 1,433 | $411,271 | $108,727 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 676 | 1,185 | $53,325 | $10,192 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 145 | $28,275 | $8,219 | 29.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 75 | 75 | $4,575 | $970.03 | 21.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 20 | 95 | $1,425 | $403.08 | 28.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 38 | 38 | $1,520 | $300.13 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 448 | 1,067 | $306,229 | $86,889 | 28.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 457 | 1,049 | $24,127 | $5,591 | 23.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 38 | 39 | $3,705 | $2,402 | 64.8% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 83 | 83 | $5,063 | $1,094 | 21.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 82 | 82 | $3,280 | $721.97 | 22.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,535 | $701.10 | 27.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 55 | 57 | $2,565 | $561.61 | 21.9% |
| 85610 | Blood test, clotting time | Office | 2021 | 22 | 101 | $1,515 | $433.29 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 308 | 534 | $153,258 | $34,821 | 22.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 338 | 592 | $13,616 | $3,194 | 23.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 22 | 23 | $8,901 | $2,045 | 23.0% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 76 | 76 | $4,636 | $1,124 | 24.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 17 | $3,315 | $747.30 | 22.5% |
About Virginia Hardaway, FNP-C
Virginia Hardaway, FNP-C is a Family healthcare provider based in Longview, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1134570856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Virginia Hardaway, FNP-C has received a total of $5,991 in payments from pharmaceutical and medical device companies, with $3,097 received in 2024. These payments were reported across 244 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,997).
As a Medicare-enrolled provider, Hardaway has provided services to 5,477 Medicare beneficiaries, totaling 9,752 services with total Medicare billing of $398,814. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Longview, TX
- Active Since 06/23/2016
- Last Updated 11/09/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134570856
Products in Payments
- WATCHMAN FLX (Device) $1,102
- ENTRESTO (Drug) $506.32
- VERQUVO (Drug) $491.93
- LEQVIO (Drug) $347.05
- WATCHMAN Access System (Device) $343.16
- JARDIANCE (Drug) $326.22
- XARELTO (Drug) $294.65
- CAMZYOS (Drug) $197.05
- ZIO XT Patch (Device) $195.73
- ELIQUIS (Drug) $184.64
- ONPATTRO (Drug) $174.49
- MITRACLIP (Device) $143.04
- INSPIRE (Device) $135.71
- KEVZARA (Biological) $128.55
- Wegovy (Drug) $125.00
- QULIPTA (Drug) $120.47
- APRETUDE (Biological) $117.52
- FARXIGA (Drug) $109.24
- LifeVest (Device) $95.38
- CARDIOMEMS (Device) $85.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Longview
Hillary Mitchell, Fnp-C, FNP-C
Family — Payments: $10,066
Family $10,066
Miss. Elizabeth Terry, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $9,658
Family $9,658
Martha Barr, Fnp-C, FNP-C
Family — Payments: $8,684
Family $8,684
Mindy Flowers, Fnp-C, FNP-C
Family — Payments: $6,051
Family $6,051
Mrs. Angela Escobar, Msn, Fnp-Bc, MSN, FNP-BC
Family — Payments: $5,734
Family $5,734
Anna Taylor, Np-C, NP-C
Family — Payments: $5,336
Family $5,336